Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Pharmaceutical Group Pays $1.2 Billion for Robust Sun Holdings

publication date: Jun 27, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Pharmaceutical Group will pay $1.2 billion to acquire Robust Sun Holdings Ltd., a company that makes drugs for CNS diseases. The transaction will add to China Pharma’s presence in finished drugs and reduce its focus on intermediates and APIs. China Pharma will purchase Robust Sun from Joyful Horizon Ltd. All three entities are affiliated with Hony Capital, the Hong Kong-headquartered PE firm that is the largest in Asia. More details....

Stock Symbol: (HK: 1093)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...